Navigation Links
Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets
Date:10/31/2007

SAN CARLOS, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2007 on Wednesday, November 7, 2007, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call for analysts and investors beginning at 5:00 p.m. Eastern Time (ET).

Investors can access the press release and a live audio-only Webcast of the conference call through a link that is posted on the Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through November 21, 2007.

To access the conference call, follow these instructions:

Dial: (800) 299-6183 (U.S.); (617) 801-9713 (international)

Passcode: 21153437 (Howard Robin is the host)

An audio replay will be available shortly following the call through November 21, 2007 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 86766898.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development platforms. Nektar PEGylation and pulmonary technology, expertise, and manufacturing capabilities have enabled ten approved products for part
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. OHSU Researchers Announce New Discovery
2. PM announces a new health care order for India
3. Partnership Between Diabetes India And Elsevier Announced
4. US Politicians Urge Movie Moghuls To Add Anti-Smoking Announcements
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Jackson 26amp 3B Coker Promotes Tony Rico to Senior VP of Operations 59618 1Jackson 26amp 3B Coker Promotes Tony Rico to Senior VP of Operations 59618 2Cell Therapeutics Inc Annual Meeting of Shareholders Scheduled for Tuesday October 20 2009 59613 1Cell Therapeutics Inc Annual Meeting of Shareholders Scheduled for Tuesday October 20 2009 59613 2Herley Reports Fourth Quarter and Year End Results 59611 1Herley Reports Fourth Quarter and Year End Results 59611 2Herley Reports Fourth Quarter and Year End Results 59611 3Herley Reports Fourth Quarter and Year End Results 59611 4Herley Reports Fourth Quarter and Year End Results 59611 5Herley Reports Fourth Quarter and Year End Results 59611 6Herley Reports Fourth Quarter and Year End Results 59611 7Herley Reports Fourth Quarter and Year End Results 59611 8Herley Reports Fourth Quarter and Year End Results 59611 9Herley Reports Fourth Quarter and Year End Results 59611 10Herley Reports Fourth Quarter and Year End Results 59611 11Herley Reports Fourth Quarter and Year End Results 59611 12